However, mutated IDH1, when co-expressed with inactivating TP53 and alpha thalassemia/mental retardation syndrome X-linked gene mutations in gliomas, induces genome stability and enhances the DNA damage response, triggering resistance to IR [118]. The gene discussed is TP53; the disease is central nervous system cancer.